...Continued

Boost Your Salon Business with GK Hair - Unveiling the Exclusive Benefits for Stylists

Retrieved on: 
Thursday, February 8, 2024

Online Classes for Continued Education: GK Hair is committed to the ongoing education of stylists.

Key Points: 
  • Online Classes for Continued Education: GK Hair is committed to the ongoing education of stylists.
  • Our online classes are crafted to help stylists stay ahead of the curve in the ever-evolving world of hair care and styling.
  • Affiliate Program – Grow with GK Hair: The GK Hair Affiliate Program presents an extraordinary opportunity for stylists to grow alongside our brand.
  • We invite stylists and salon owners to explore these exclusive benefits and join the GK Hair family.

UNIFI®, Makers of REPREVE®, Announces Second Quarter Fiscal 2024 Results

Retrieved on: 
Wednesday, January 31, 2024

Unifi, Inc. (NYSE: UFI) (together with its consolidated subsidiaries, “UNIFI”), makers of REPREVE and one of the world’s leading innovators in recycled and synthetic yarns, today released operating results for the second fiscal quarter ended December 31, 2023.

Key Points: 
  • Unifi, Inc. (NYSE: UFI) (together with its consolidated subsidiaries, “UNIFI”), makers of REPREVE and one of the world’s leading innovators in recycled and synthetic yarns, today released operating results for the second fiscal quarter ended December 31, 2023.
  • Net sales were $136.9 million, an increase of 0.5% from the second quarter of fiscal 2023, driven by higher sales volumes that were muted by lower pricing in response to lower raw material costs.
  • Adjusted EBITDA, which also excludes $5.1 million of restructuring costs, was ($5.5) million, compared to ($13.0) million for the second quarter of fiscal 2023.
  • Additionally, UNIFI expects sequential improvement from the third quarter to the fourth quarter of fiscal 2024.

LEONOVUS ANNOUNCES SALE OF ASSETS AND DEBT SETTLEMENT

Retrieved on: 
Wednesday, January 31, 2024

The Transaction is subject to the requirement that the Company and CRL enter into a definitive purchase and sale agreement (the "Definitive Agreement").

Key Points: 
  • The Transaction is subject to the requirement that the Company and CRL enter into a definitive purchase and sale agreement (the "Definitive Agreement").
  • "Our historical quarterly Management Discussion and Analysis noted the Company's need to find a strategic solution such as merger, acquisition, or sale of assets.
  • Related party involvement in the Debt Settlement constitutes a "related party transaction".
  • The Company expects to complete the debt settlement following completion of the Transaction.

Ring Energy Announces Issuance of 2023 Sustainability Report

Retrieved on: 
Thursday, December 28, 2023

THE WOODLANDS, Texas, Dec. 28, 2023 (GLOBE NEWSWIRE) -- Ring Energy, Inc. (NYSE American: REI) (“Ring” or the “Company”) today announced that it has issued its 2023 Sustainability Report (the “2023 Report”), which is available on the Company’s website at www.ringenergy.com under the “Sustainability” tab.

Key Points: 
  • THE WOODLANDS, Texas, Dec. 28, 2023 (GLOBE NEWSWIRE) -- Ring Energy, Inc. (NYSE American: REI) (“Ring” or the “Company”) today announced that it has issued its 2023 Sustainability Report (the “2023 Report”), which is available on the Company’s website at www.ringenergy.com under the “Sustainability” tab.
  • The report provides updated and comprehensive information about Ring’s Environmental, Social and Governance (“ESG”) initiatives and related key performance indicators.
  • During 2022 and into 2023, the Company has executed a number of its targeted ESG initiatives, and these projects are discussed in the 2023 Report.
  • We are confident our 2023 Report showcases our progress on these important fronts.”

In Vitro Diagnostic (IVD) Trends and Market Report 2023 - New Opportunities in Multiplex Testing, Next-Generation Sequencing, Artificial Intelligence and Disruptive Technologies - ResearchAndMarkets.com

Retrieved on: 
Friday, December 22, 2023

The "In Vitro Diagnostic (IVD) Trends and Market Update: 2023" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "In Vitro Diagnostic (IVD) Trends and Market Update: 2023" report has been added to ResearchAndMarkets.com's offering.
  • In vitro diagnostic (IVD) testing is getting back to regular business and continues to be a driving force in the practice of medicine.
  • Trends highlighted throughout Q3 2023 include:
    In IVD Trends and Market Update Report, you'll discover the following:
    What's Driving Growth in the IVD Market in Q3 and the last half of 2023?
  • What Product Trends and New Developments Will Shape the IVD Market in the last half of 2023?

Clever Leaves Reports Third Quarter 2023 Results

Retrieved on: 
Thursday, November 9, 2023

TOCANCIPÁ, Colombia, Nov. 09, 2023 (GLOBE NEWSWIRE) -- Clever Leaves Holdings Inc. (NASDAQ: CLVR, CLVRW) (“Clever Leaves” or the “Company”), a global medicinal cannabis company, is reporting financial and operating results for the third quarter ended September 30, 2023. All financial information is provided in US dollars unless otherwise indicated.

Key Points: 
  • “Our third quarter results reflect our commitment to enhancing our commercial strategy and Colombian production, as well as optimizing our expenses,” said Andres Fajardo, CEO of Clever Leaves.
  • Same Year-Ago Quarter1
    Revenue in the third quarter of 2023 increased 33% to $3.8 million compared to $2.9 million for the same period in 2022.
  • The revisions also reflect softness experienced in the first half of the year in the specialty channel of Clever Leaves’ non-cannabinoid segment.
  • Clever Leaves will conduct a conference call today at 5:00 p.m. Eastern time to discuss its results for the third quarter ended September 30, 2023.

NJII Welcomes Michael Edmondson, Ph.D. as Vice President for Continued Learning

Retrieved on: 
Tuesday, December 12, 2023

NEWARK, N.J., Dec. 12, 2023 /PRNewswire-PRWeb/ -- New Jersey Innovation Institute (NJII) has appointed Michael Edmondson, Ph.D. as its Vice President for Continued Learning to oversee the Professional & Corporate Education division. Edmondson also serves as the Associate Provost for Continued Learning at New Jersey Institute of Technology (NJIT). The Continued Learning operating unit is a joint venture between NJII and NJIT.

Key Points: 
  • New Jersey Innovation Institute (NJII) has appointed Michael Edmondson, Ph.D. as its Vice President for Continued Learning to oversee the Professional & Corporate Education division.
  • NEWARK, N.J., Dec. 12, 2023 /PRNewswire-PRWeb/ -- New Jersey Innovation Institute (NJII) has appointed Michael Edmondson, Ph.D. as its Vice President for Continued Learning to oversee the Professional & Corporate Education division.
  • Continued Learning extends the mission of NJIT by partnering with NJII and offers expansive learning and development opportunities in Newark or Jersey City, online, or at a client's office.
  • Prior to joining NJIT and NJII, Edmondson managed the continued learning offices at both the community college and university levels.

U.S. Gold Corp. to Participate at 2023 Mines and Money @ Resourcing Tomorrow Conference in London

Retrieved on: 
Wednesday, November 15, 2023

CHEYENNE, Wyo., Nov. 15, 2023 /PRNewswire/ -- U.S. Gold Corp. (Nasdaq: USAU) ("U.S. Gold" or the "Company") is pleased to announce that it will be presenting and exhibiting at the Mines and Money @ Resourcing Tomorrow conference (the "Conference"), to be held in London at the end of November.

Key Points: 
  • CHEYENNE, Wyo., Nov. 15, 2023 /PRNewswire/ -- U.S. Gold Corp. (Nasdaq: USAU) ("U.S. Gold" or the "Company") is pleased to announce that it will be presenting and exhibiting at the Mines and Money @ Resourcing Tomorrow conference (the "Conference"), to be held in London at the end of November.
  • The Conference will be held in-person at the Business Design Centre in London, UK from November 28-30, 2023.
  • Many of the world's largest mining companies will be attending and presenting, including Barrick Gold Corporation, BHP Group Limited and Rio Tinto Group.
  • The Company expects to have a full schedule of one-on-one meetings at the conference in addition to George Bee's presentation.

Latham Group, Inc. Reports Third Quarter Fiscal 2023 Financial Results

Retrieved on: 
Tuesday, November 7, 2023

LATHAM, N.Y., Nov. 07, 2023 (GLOBE NEWSWIRE) -- Latham Group, Inc. (“Latham” or “the Company”) (Nasdaq: SWIM), the largest designer, manufacturer and marketer of in-ground residential swimming pools in North America, Australia and New Zealand, today announced financial results for the third quarter and first nine months of its fiscal year 2023 ended September 30, 2023.

Key Points: 
  • Gross profit for the third quarter of fiscal 2023 was $48.1 million, down $10.7 million or 18.2%, from $58.9 million in the prior year’s third quarter.
  • Adjusted EBITDA for the third quarter of fiscal 2023 was $36.1 million, down $6.2 million or 14.6%, from $42.3 million in the prior year’s third quarter.
  • Capital expenditures totaled $4.9 million in the third quarter of fiscal 2023 compared to $12.3 million in the third quarter of fiscal 2022.
  • Latham has updated its net sales, adjusted EBITDA and capital expenditures guidance for the full year fiscal 2023.

Morphic Announces Corporate Highlights and Financial Results for the Third Quarter 2023

Retrieved on: 
Friday, November 3, 2023

WALTHAM, Mass., Nov. 03, 2023 (GLOBE NEWSWIRE) -- Morphic Therapeutic (Nasdaq: MORF), a biopharmaceutical company developing a new generation of oral integrin therapies for the treatment of serious chronic diseases, today reported corporate highlights and financial results for the third quarter 2023.

Key Points: 
  • -Ended third quarter with $725.1 million in cash, cash equivalents, and marketable securities providing runway into the second half of 2027-
    WALTHAM, Mass., Nov. 03, 2023 (GLOBE NEWSWIRE) -- Morphic Therapeutic (Nasdaq: MORF), a biopharmaceutical company developing a new generation of oral integrin therapies for the treatment of serious chronic diseases, today reported corporate highlights and financial results for the third quarter 2023.
  • “Morphic presented a comprehensive set of positive results from the 12-week induction phase of the EMERALD-1 study of MORF-057 in UC, showing consistent efficacy across-the-board for patients, while demonstrating no safety signals.
  • These results are particularly impressive, given that enrollment was skewed towards the severe end of the spectrum of moderately-to-severely active UC.
  • The increase was due to increased non-cash stock-based compensation expenses and higher payroll costs
    As of September 30, 2023, Morphic had cash, cash equivalents and marketable securities of $725.1 million, compared to $731.4 million as of June 30, 2023.